Patents Assigned to VITAMERICA UG (HAFTUNGSBESCHRANKT)
  • Patent number: 11826406
    Abstract: There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by administration of glucose isomerase. Other embodiments are also disclosed.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: November 28, 2023
    Assignee: VITAMERICA UG (HAFTUNGSBESCHRANKT)
    Inventors: Daniel Henry Wyrobnik, Isaac Harry Wyrobnik
  • Publication number: 20220072111
    Abstract: There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by administration of glucose isomerase. Other embodiments are also disclosed.
    Type: Application
    Filed: September 16, 2021
    Publication date: March 10, 2022
    Applicant: VITAMERICA UG (HAFTUNGSBESCHRANKT)
    Inventors: Daniel Henry WYROBNIK, Isaac Harry WYROBNIK
  • Patent number: 11147861
    Abstract: There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by administration of glucose isomerase. Other embodiments are also disclosed.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: October 19, 2021
    Assignee: VITAMERICA UG (HAFTUNGSBESCHRANKT)
    Inventors: Daniel Henry Wyrobnik, Issac Harry Wyrobnik
  • Patent number: 10842854
    Abstract: There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by administration of glucose isomerase. Other embodiments are also disclosed.
    Type: Grant
    Filed: January 15, 2018
    Date of Patent: November 24, 2020
    Assignee: VITAMERICA UG (HAFTUNGSBESCHRÄNKT)
    Inventors: Daniel Henry Wyrobnik, Isaac Harry Wyrobnik
  • Publication number: 20190282678
    Abstract: There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by administration of glucose isomerase. Other embodiments are also disclosed.
    Type: Application
    Filed: March 25, 2019
    Publication date: September 19, 2019
    Applicant: VITAMERICA UG (HAFTUNGSBESCHRANKT)
    Inventors: Daniel Henry WYROBNIK, Issac Harry WYROBNIK